Glycolysis, the sweet appetite of the tumor microenvironment
Zeinab Kooshan,
No information about this author
Lilibeth Cárdenas-Piedra,
No information about this author
Judith A. Clements
No information about this author
et al.
Cancer Letters,
Journal Year:
2024,
Volume and Issue:
600, P. 217156 - 217156
Published: Aug. 8, 2024
Cancer
cells
display
an
altered
metabolic
phenotype,
characterised
by
increased
glycolysis
and
lactate
production,
even
in
the
presence
of
sufficient
oxygen
-
a
phenomenon
known
as
Warburg
effect.
This
reprogramming
is
crucial
adaptation
that
enables
cancer
to
meet
their
elevated
energy
biosynthetic
demands.
Importantly,
tumor
microenvironment
plays
pivotal
role
shaping
sustaining
this
shift
cells.
review
explores
intricate
relationship
between
effect,
highlighting
how
communication
within
niche
regulates
cell
metabolism
impacts
progression
therapeutic
resistance.
We
discuss
potential
targeting
effect
promising
strategy,
with
aim
disrupting
advantage
enhancing
our
understanding
complex
interplay
microenvironment.
Language: Английский
The Effect of Flavonoids and Topiramate on Glucose Carbon Metabolism in a HepG2 Steatosis Cell Culture Model: A Stable Isotope Study
Li Ma,
No information about this author
Qing‐Yi Lu,
No information about this author
Shu Lim
No information about this author
et al.
Nutrients,
Journal Year:
2025,
Volume and Issue:
17(3), P. 564 - 564
Published: Jan. 31, 2025
Background:
Insufficient
treatment
options
are
available
for
metabolic
dysfunction-associated
steatotic
liver
disease
(MASLD).
Flavonoids
and
topiramate
have
been
studied
weight
loss
but
need
investigation
into
their
effects
on
metabolism.
This
study’s
aim
was
to
examine
the
of
flavonoids
or
glucose
carbon
flux
in
a
cell
culture
model
steatosis.
Methods:
Steatosis
induced
HepG2
cells
through
exposure
oleic
acid
(OA,
0.5
mml/L)
conjugated
bovine
serum
albumin
(2:1).
Additionally,
50%
U13C-glucose
supplied
medium
as
stable
isotope
tracer.
Cells
were
treated
with
DMSO,
10
μM
naringenin,
morin,
silibinin,
(44
μM)
72
h.
A
non-steatotic,
untreated
control
included.
Cell
extracts
analyzed
by
gas
chromatography/mass
spectrometry
mass
isotopomer
distribution
analysis
glycogen
synthesis,
de
novo
fatty
tricarboxylic
(TCA)
cycle
activity,
ribose
synthesis.
Groups
compared
ANOVA
Tukey’s
pair-wise
testing.
Results:
Compared
controls,
OA-exposed
exhibited
increased
lipid
accumulation
ORO
staining
(1.6-fold),
enhanced
palmitate
reduced
pyruvate
carboxylase/pyruvate
dehydrogenase
(PC/PDH)
ratio,
Treatment
silibinin
ameliorated
(1.3-fold)
mitigated
enhancement
Morin-treated
synthesis
suppressed
Conclusions:
Potential
mechanisms
may
include
suppression
relative
decrease
PDH
pathway.
Further
studies
needed
potential
utility
MASLD
based
specific
effects.
Language: Английский
Silibinin, a potential fasting mimetic, inhibits hepatocellular carcinoma by triggering extrinsic apoptosis
Biying Xiao,
No information about this author
Yanyu Jiang,
No information about this author
Shuying Yuan
No information about this author
et al.
MedComm,
Journal Year:
2024,
Volume and Issue:
5(1)
Published: Jan. 1, 2024
Abstract
Fasting,
without
inducing
malnutrition,
has
been
shown
to
have
various
beneficial
effects,
including
the
inhibition
of
tumor
initiation
and
progression.
However,
prolonged
fasting
poses
challenges
for
many
cancer
patients,
particularly
those
in
intermediate
terminal
stages.
Thus,
there
is
an
urgent
need
development
mimetics
which
harness
protective
effects
but
more
suitable
patients.
In
this
study,
we
first
highlighted
pivotal
role
silibinin
AMP‐activated
protein
kinase
(AMPK)
pathway
may
serve,
as
a
potential
mimetic
via
screening
hepatoprotective
drugs.
Further
metabolic
analysis
showed
that
inhibited
adenosine
triphosphate
(ATP)
levels,
glucose
uptake
diminished
glycolysis
process,
further
confirmed
served
mimetic.
addition,
synergized
with
silibinin,
or
used
independently,
suppress
growth
hepatocellular
carcinoma
(HCC)
vivo.
Mechanistically,
upregulated
death
receptor
5
(DR5)
through
AMPK
activation,
thus
promoting
extrinsic
apoptosis
inhibiting
HCC
both
vitro
Inhibition
using
small
interfering
RNA
(siRNA)
compound
C,
inhibitor,
significantly
attenuated
upregulation
DR5
apoptotic
response
induced
by
silibinin.
These
findings
suggest
holds
promise
serve
adjuvant
drug
treatment.
Language: Английский
Nanomedicines via the pulmonary route: a promising strategy to reach the target?
Drug Delivery and Translational Research,
Journal Year:
2024,
Volume and Issue:
14(8), P. 2276 - 2297
Published: April 8, 2024
Language: Английский
Fasting as Cancer Treatment: Myth or Breakthrough in Oncology
Ghizal Fatima,
No information about this author
Abbas A Mehdi,
No information about this author
Ján Fedačko
No information about this author
et al.
Cureus,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 29, 2025
The
concept
of
fasting
as
a
potential
cancer
treatment
has
garnered
increasing
interest,
particularly
in
light
emerging
evidence
linking
dietary
interventions
to
progression
and
therapy
outcomes.
This
article
explores
whether
fasting,
either
intermittent
or
prolonged,
can
be
viable
standalone
for
if
its
therapeutic
lies
adjunctive
role.
Current
research
suggests
that
induces
metabolic
shift,
which
may
inhibit
cell
proliferation
by
depriving
them
essential
nutrients.
Additionally,
been
shown
enhance
the
body's
stress
resistance,
promote
autophagy,
possibly
make
cells
more
vulnerable
standard
treatments
such
chemotherapy
radiotherapy.
However,
application
sole
remains
controversial
lacks
substantial
clinical
validation.
While
animal
models
vitro
studies
indicate
promising
results,
translation
human
trials
is
complex,
with
various
types
responding
differently
interventions.
Moreover,
concerns
about
malnutrition,
loss
muscle
mass,
overall
health
patients
undergoing
without
supervision
must
addressed.
paper
critically
examines
myth
reality
surrounding
treatment,
reviewing
key
provide
comprehensive
understanding
efficacy
safety.
hold
promise
supportive
therapy,
combination
traditional
treatments,
there
currently
insufficient
support
use
primary
modality.
Further
needed
establish
parameters
might
beneficial,
specific
types,
patient
populations,
optimal
regimens.
Thus,
while
idea
breakthrough
compelling,
it
complementary
approach
rather
than
solution
oncology.
Language: Английский
Potential applications and effects of silymarin in domestic animals – a review
Dražen Đuričić,
No information about this author
Mirela Sablić
No information about this author
Veterinarska stanica,
Journal Year:
2024,
Volume and Issue:
56(2), P. 257 - 264
Published: Aug. 16, 2024
Silymarin
is
a
mixture
of
flavonolignan
fractions
from
the
medicinal
plant
milk
thistle,
which
primarily
used
as
hepatoprotector
in
humans
and
animals,
acts
an
antioxidant,
anti-inflammatory,
antifibrotic,
antiapoptotic
agent.
As
dietary
supplement,
it
increasingly
to
treat
various
liver
diseases,
some
intoxications,
prevent
side
effects
chemotherapy
protect
kidneys
dogs,
birds,
poultry,
rabbits,
cats,
horses
other
animals.
The
use
silymarin
dairy
cows
showed
improved
biochemical
profile
cows,
reduced
occurrence
ketosis
increased
production.
In
pigs,
nutrient
digestibility,
total
average
daily
feed
intake,
weight
gain
improved,
while
sport
horses,
supplementation
accelerated
return
cortisol
levels
pre-exercise
levels.
Lipidosis
or
fatty
disease
common
disorder
among
captive
parrots.
After
long-term
administration
100–150
mg/kg
food
every
8–12
hours,
health
condition
significantly
according
testimonies
parrot
owners
veterinarians.
intensive
poultry
production
systems,
broilers
hepatotonic,
improve
carcass
characteristics,
boost
immune
system
intestinal
health,
growth
promoter,
laying
hens
egg
quality.
addition,
mitigated
negative
mycotoxins
broilers,chickens
Japanese
quails.
Although
numerous
studies
are
known
about
effect
thistle
silymarin,
their
on
animals
not
yet
widespread.
Language: Английский
A Comprehensive Review on Molecular Mechanisms, Treatments, and Brief Role of Natural Products in Hepatocellular Cancer
Linlin Jiang,
No information about this author
Qin Meng,
No information about this author
Lixiu Liu
No information about this author
et al.
Natural Product Communications,
Journal Year:
2024,
Volume and Issue:
19(9)
Published: Sept. 1, 2024
Most
initial
liver
cancers
are
hepatocellular
carcinomas
(HCC),
which
make
up
the
vast
majority
of
cases.
Hepatitis
B
or
C
virus
infection
as
well
alcohol
consumption
is
among
key
risk
factors.
The
significance
most
intriguing
soluble
factors
indicators
for
early
diagnosis
and
suggested
targets
therapy
in
light
increasing
challenges
precision
medicine.
development
HCC
influenced
by
a
complex
combination
between
pro-inflammatory
anti-inflammatory
cytokines
their
signalling
cascades.
Recently,researchers
aims
to
assess
potential
number
distinct
molecular
cascade/cascade
including
function
players
with
particular
underlying
etiologies.
Increasing
our
knowledge
signaling
network
that
links
retro
differentiation
inflammationmay
help
us
find
novel
therapeutic
develop
combined
therapies
treatments
work
against
tumors
significant
degree
heterogeneity.
With
nursing
processes
at
its
center,
comprehensive
care
new
paradigm
combines
benefits
primary
group
nursin
g
perfect
synthesis
many
metrics
like
philosophy,
plan,
quality
evaluation.
In
order
treat
patients
serious
diseases
cancer,
it
can
conduct
interventions
item
accordance
unique
disease
conditions
each
patient
combine
efficient
approaches
high-quality
modes.
Dietary
natural
products,
fruits,
vegetables,
spices,
may
prevent
cancer
inhibiting
tumor
growth,
protecting
liver,
enhancing
chemotherapy.
Language: Английский